Literature DB >> 12970641

Acute chylothorax in children: selective retention of memory T cells and natural killer cells.

Jordan S Orange1, Raif S Geha, Francisco A Bonilla.   

Abstract

OBJECTIVE: To assess for immunodeficiency in patients with hypogammaglobulinemia in the setting of draining acute chylothorax. STUDY
DESIGN: Humoral and cellular immunity was evaluated in 8 patients with chylothorax. Chylous fluid was also analyzed to document cellular losses. Data regarding clinical course and immunologic characteristics were reviewed retrospectively.
RESULTS: All patients had hypogammaglobulinemia (IgG=179+/-35 mg/dL) as well as lymphopenia (985+/-636 cells/mm(3)). T cells were decreased and natural killer cells increased in peripheral blood. The converse was found in chylous fluid. The ratio of CD3+/CD45RA+ naive: CD3+/CD45RO+ memory T cells was greater in chyle than in peripheral blood. In vitro proliferative responses to antigens and mitogens were similar to control subjects, and previously immunized patients maintained evidence of protective vaccine-specific humoral immunity. To treat hypogammaglobulinemia, patients received intravenous immunoglobulin (IVIG) to maintain IgG within normal range; 6 of 8 patients had serious infections before receiving IVIG compared with 4 of 8 patients during the period of IVIG administration.
CONCLUSION: Draining chylothorax resulted in IgG and lymphocyte depletion with preferential retention of memory T cells and natural killer cells in the circulation. Overall, protective-specific antibody levels and T cell function were maintained. IVIG administration did not lead to discernible protection from infectious complications in this small group of patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970641     DOI: 10.1067/S0022-3476(03)00305-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Octreotide in the management of postoperative chylothorax.

Authors:  L Rosti; F De Battisti; G Butera; S Cirri; M Chessa; A Delogu; M Drago; A Giamberti; G Pomè; M Carminati; A Frigiola
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 2.  Pleural effusions in hematologic malignancies and their management with indwelling pleural catheters.

Authors:  Erik Vakil; Carlos A Jimenez; Saadia A Faiz
Journal:  Curr Opin Pulm Med       Date:  2018-07       Impact factor: 3.155

Review 3.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

4.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

5.  SARS-CoV-2 associated with death in an infant with congenital chylothorax.

Authors:  Handan Bezirganoglu; Nilufer Okur
Journal:  J Paediatr Child Health       Date:  2021-05-18       Impact factor: 1.929

6.  Chylothorax caused by blunt trauma: Case review and management proposal.

Authors:  Brandon T Bacon; Wayne Mashas
Journal:  Trauma Case Rep       Date:  2020-05-21

Review 7.  Therapeutic use of immunoglobulins.

Authors:  E Richard Stiehm; Jordan S Orange; Mark Ballow; Heather Lehman
Journal:  Adv Pediatr       Date:  2010

8.  Thoracic duct identification with indocyanine green fluorescence during minimally invasive esophagectomy with patient in prone position.

Authors:  Massimo Vecchiato; Antonio Martino; Massimo Sponza; Alessandro Uzzau; Antonio Ziccarelli; Federico Marchesi; Roberto Petri
Journal:  Dis Esophagus       Date:  2020-12-07       Impact factor: 3.429

9.  High-volume bilateral chylothorax presenting with hypoxemia and shock in a pediatric patient following tracheostomy revision: a case report.

Authors:  Aaron L Thatcher; Jane Yu; Kevin W Kuo
Journal:  J Med Case Rep       Date:  2015-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.